NewslettersImmune Regulation NewsUncategorizedElongation Factor-2 Kinase Is a Critical Determinant of the Fate and Antitumor Immunity of CD8+ T CellsBy Justin.choi - February 3, 2022011eEF-2K KO CD8+ T cells were more metabolically active and showed hyperactivation of the Akt-mTOR-S6K pathway.[Science Advances]Sorry, but the selected Zotpress account can't be found.Full Article